To use all functions of this page, please activate cookies in your browser.
With an accout for my.chemeurope.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Epzicom is the brand name for a pharmaceutical treatment for HIV infection. It is a fixed dose combination of lamivudine (3TC, Epivir) and abacavir (ABC, Ziagen). The combination of the two drugs has a stronger effect than either drug alone.
Additional recommended knowledge
Lamivudine and abacavir are both nucleoside reverse transcriptase inhibitors (NRTI).
|This article is licensed under the GNU Free Documentation License. It uses material from the Wikipedia article "Epzicom". A list of authors is available in Wikipedia.|